David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Shake Shack
SHAK
$2.93B
| $6.92M | 0.01% |
+116,961
| New | +$5.99M |
|
|
SAFM
1302
DELISTED
Sanderson Farms Inc
SAFM
| $6.92M | 0.01% |
+52,473
| New | +$6.29M |
|
1303
Steven Madden
SHOO
$3.29B
| $6.92M | 0.01% |
204,379
-88,419
| -30% | -$2.89M |
|
|
SPLK
1304
PUT
DELISTED
Splunk Inc
SPLK
| $6.9M | 0.01% |
55,400
+25,000
| +82% | +$3.12M |
|
1305
American Superconductor
AMSC
$1.41B
| $6.9M | 0.01% |
536,532
+274,680
| +105% | +$3.74M |
|
1306
CALL
Philip Morris
PM
$303B
| $6.89M | 0.01% |
78,000
-62,000
| -44% | -$4.99M |
|
|
CIC.U
1307
DELISTED
Capitol Investment Corp. IV
CIC.U
| $6.87M | 0.01% |
650,000
| – | – |
|
1308
CALL
Humana
HUM
$46.6B
| $6.86M | 0.01% |
25,800
-36,500
| -59% | -$10.5M |
|
1309
Semtech
SMTC
$12.9B
| $6.86M | 0.01% |
134,800
-78,385
| -37% | -$4.05M |
|
1310
CALL
EOG Resources
EOG
$76.5B
| $6.83M | 0.01% |
71,800
+51,800
| +259% | +$4.94M |
|
1311
Alpha and Omega Semiconductor
AOSL
$793M
| $6.82M | 0.01% |
592,692
-33,474
| -5% | -$370K |
|
|
B
1312
Barrick Mining
B
$78.6B
| $6.81M | 0.01% |
496,940
-170,963
| -26% | -$2.21M |
|
|
VIVO
1313
DELISTED
Meridian Bioscience Inc
VIVO
| $6.78M | 0.01% |
384,707
+467
| +0.1% | +$7.77K |
|
1314
SK Telecom
SKM
$15.2B
| $6.77M | 0.01% |
167,869
+30,404
| +22% | +$1.28M |
|
1315
PUT
Stanley Black & Decker
SWK
$15B
| $6.77M | 0.01% |
49,700
-14,900
| -23% | -$1.94M |
|
1316
PUT
Trade Desk
TTD
$6.12B
| $6.75M | 0.01% |
341,000
-193,000
| -36% | -$3.16M |
|
1317
ePlus
PLUS
$2.23B
| $6.73M | 0.01% |
151,980
-16,742
| -10% | -$696K |
|
|
CTRA
1318
DELISTED
Coterra Energy
CTRA
| $6.7M | 0.01% |
256,654
-407,138
| -61% | -$10.2M |
|
|
EBSB
1319
DELISTED
Meridian Bancorp, Inc.
EBSB
| $6.7M | 0.01% |
426,831
-24,183
| -5% | -$379K |
|
1320
Adecoagro
AGRO
$1.62B
| $6.69M | 0.01% |
971,243
+103,047
| +12% | +$734K |
|
|
LMNX
1321
DELISTED
Luminex Corp
LMNX
| $6.69M | 0.01% |
290,537
+155,029
| +114% | +$3.89M |
|
1322
Rush Enterprises Class A
RUSHA
$8.36B
| $6.67M | 0.01% |
358,945
+70,931
| +25% | +$1.26M |
|
1323
Axogen
AXGN
$2.73B
| $6.67M | 0.01% |
316,639
+160,318
| +103% | +$2.93M |
|
|
GWB
1324
DELISTED
Great Western Bancorp, Inc.
GWB
| $6.65M | 0.01% |
210,499
+97,335
| +86% | +$3.38M |
|
1325
CALL
US Bancorp
USB
$98.3B
| $6.63M | 0.01% |
+137,600
| New | +$6.9M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.